| 1 |
Management of Endocrinopathies in Pregnancy: A Review of Current Evidence |
|
|
| Daniela Calina,Anca Docea,Kirill Golokhvast,Stavros Sifakis,Aristides Tsatsakis,Antonis Makrigiannakis |
|
| International Journal of Environmental Research and Public Health. 2019; 16(5): 781 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
SAFETY AND EFFICACY OF CABERGOLINE ON PREGNANCY OUTCOME IN PATIENTS WITH MICROPROLACTINOMA |
|
|
| Pattanaik S.R |
|
| Journal of Evidence Based Medicine and Healthcare. 2018; 5(25): 1877 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Prolactinoma through the female life cycle |
|
|
| Deirdre Cocks Eschler,Pedram Javanmard,Katherine Cox,Eliza B. Geer |
|
| Endocrine. 2017; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Second Attempt of Cabergoline Withdrawal in Patients with Prolactinomas after a Failed First Attempt: Is it Worthwhile? |
|
|
| Lucio Vilar,José Luciano Albuquerque,PatrÃcia Sampaio Gadelha,Frederico Rangel Filho,Aline Maria C. Siqueira,MaÃra Melo da Fonseca,Karoline Frazão Viana,Barbara Sales Gomes,Ruy Lyra |
|
| Frontiers in Endocrinology. 2015; 6 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Prolactinomas, cabergoline, and pregnancy |
|
|
| Andrea Glezer,Marcello D. Bronstein |
|
| Endocrine. 2014; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Clinical Experience in the Screening and Management of a Large Kindred With Familial Isolated Pituitary Adenoma Due to an Aryl Hydrocarbon Receptor Interacting Protein (AIP) Mutation |
|
|
| Fred Williams,Steven Hunter,Lisa Bradley,Harvinder S. Chahal,Helen L. Storr,Scott A. Akker,Ajith V. Kumar,Stephen M. Orme,Jane Evanson,Noina Abid,Patrick J. Morrison,Márta Korbonits,A. Brew Atkinson |
|
| The Journal of Clinical Endocrinology & Metabolism. 2014; 99(4): 1122 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Cabergoline therapy for Macroprolactinoma during pregnancy: A case report |
|
|
| Hira Shahzad,Aisha Sheikh,Lumaan Sheikh |
|
| BMC Research Notes. 2012; 5(1): 606 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
